139 related articles for article (PubMed ID: 37163716)
21. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma.
Yang C; Mei H; Peng L; Jiang F; Xie B; Li J
Comput Math Methods Med; 2020; 2020():7397132. PubMed ID: 33456497
[TBL] [Abstract][Full Text] [Related]
23. Regulation of Oncogenic Targets by
Okada R; Koshizuka K; Yamada Y; Moriya S; Kikkawa N; Kinoshita T; Hanazawa T; Seki N
Cells; 2019 Nov; 8(12):. PubMed ID: 31795200
[TBL] [Abstract][Full Text] [Related]
24. Integrative Analysis of miRNAs Identifies Clinically Relevant Epithelial and Stromal Subtypes of Head and Neck Squamous Cell Carcinoma.
Holt J; Walter V; Yin X; Marron D; Wilkerson MD; Choi HY; Zhao X; Jo H; Hayes DN; Ko YH
Clin Cancer Res; 2021 Feb; 27(3):831-842. PubMed ID: 33148669
[TBL] [Abstract][Full Text] [Related]
25. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
[TBL] [Abstract][Full Text] [Related]
26. Identification of Antitumor
Minemura C; Asai S; Koma A; Kikkawa N; Kato M; Kasamatsu A; Uzawa K; Hanazawa T; Seki N
Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886008
[TBL] [Abstract][Full Text] [Related]
27. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
[TBL] [Abstract][Full Text] [Related]
28. An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma.
Citron F; Armenia J; Franchin G; Polesel J; Talamini R; D'Andrea S; Sulfaro S; Croce CM; Klement W; Otasek D; Pastrello C; Tokar T; Jurisica I; French D; Bomben R; Vaccher E; Serraino D; Belletti B; Vecchione A; Barzan L; Baldassarre G
Clin Cancer Res; 2017 Jul; 23(14):3769-3780. PubMed ID: 28174235
[No Abstract] [Full Text] [Related]
29. A risk score system based on a six-microRNA signature predicts the overall survival of patients with ovarian cancer.
Zhou M; Wu T; Yuan Y; Dong SJ; Zhang ZM; Wang Y; Wang J
J Ovarian Res; 2022 May; 15(1):54. PubMed ID: 35513874
[TBL] [Abstract][Full Text] [Related]
30. Expression profiles of miR-29c, miR-200b and miR-375 in tumour and tumour-adjacent tissues of head and neck cancers.
Hudcova K; Raudenska M; Gumulec J; Binkova H; Horakova Z; Kostrica R; Babula P; Adam V; Masarik M
Tumour Biol; 2016 Sep; 37(9):12627-12633. PubMed ID: 27440205
[TBL] [Abstract][Full Text] [Related]
31. Identification of prognostic marker genes in head and neck squamous cell carcinoma: A study based on The Cancer Genome Atlas database and experimental validation.
Zhong Q; Zhou L; Zhu D
J Oral Pathol Med; 2021 Oct; 50(9):891-901. PubMed ID: 33880801
[TBL] [Abstract][Full Text] [Related]
32. Identification of Tumor Suppressive Genes Regulated by
Oshima S; Asai S; Seki N; Minemura C; Kinoshita T; Goto Y; Kikkawa N; Moriya S; Kasamatsu A; Hanazawa T; Uzawa K
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201353
[TBL] [Abstract][Full Text] [Related]
33. Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.
Childs G; Fazzari M; Kung G; Kawachi N; Brandwein-Gensler M; McLemore M; Chen Q; Burk RD; Smith RV; Prystowsky MB; Belbin TJ; Schlecht NF
Am J Pathol; 2009 Mar; 174(3):736-45. PubMed ID: 19179615
[TBL] [Abstract][Full Text] [Related]
34. Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05).
Joerger M; Baty F; Früh M; Droege C; Stahel RA; Betticher DC; von Moos R; Ochsenbein A; Pless M; Gautschi O; Rothschild S; Brauchli P; Klingbiel D; Zappa F; Brutsche M
Lung Cancer; 2014 Aug; 85(2):306-13. PubMed ID: 24928469
[TBL] [Abstract][Full Text] [Related]
35. Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas.
Ma B; Li H; Qiao J; Meng T; Yu R
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33111959
[TBL] [Abstract][Full Text] [Related]
36. Identification of Prognosis Associated microRNAs in HNSCC Subtypes Based on TCGA Dataset.
Chamorro Petronacci CM; García García A; Padín Iruegas E; Rivas Mundiña B; Lorenzo Pouso AI; Pérez Sayáns M
Medicina (Kaunas); 2020 Oct; 56(10):. PubMed ID: 33066067
[No Abstract] [Full Text] [Related]
37. Four PTEN-targeting co-expressed miRNAs and ACTN4- targeting miR-548b are independent prognostic biomarkers in human squamous cell carcinoma of the oral tongue.
Berania I; Cardin GB; Clément I; Guertin L; Ayad T; Bissada E; Nguyen-Tan PF; Filion E; Guilmette J; Gologan O; Soulieres D; Rodier F; Wong P; Christopoulos A
Int J Cancer; 2017 Dec; 141(11):2318-2328. PubMed ID: 28779483
[TBL] [Abstract][Full Text] [Related]
38. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
[TBL] [Abstract][Full Text] [Related]
39. A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
Zhang J; Chong CC; Chen GG; Lai PB
PLoS One; 2015; 10(6):e0128628. PubMed ID: 26046780
[TBL] [Abstract][Full Text] [Related]
40. Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma.
Hou B; Ishinaga H; Midorikawa K; Shah SA; Nakamura S; Hiraku Y; Oikawa S; Murata M; Takeuchi K
Cancer Biol Ther; 2015; 16(7):1042-6. PubMed ID: 25950115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]